These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 11507060)
1. Overexpression and overactivation of Akt in thyroid carcinoma. Ringel MD; Hayre N; Saito J; Saunier B; Schuppert F; Burch H; Bernet V; Burman KD; Kohn LD; Saji M Cancer Res; 2001 Aug; 61(16):6105-11. PubMed ID: 11507060 [TBL] [Abstract][Full Text] [Related]
2. Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. Vasko V; Saji M; Hardy E; Kruhlak M; Larin A; Savchenko V; Miyakawa M; Isozaki O; Murakami H; Tsushima T; Burman KD; De Micco C; Ringel MD J Med Genet; 2004 Mar; 41(3):161-70. PubMed ID: 14985374 [TBL] [Abstract][Full Text] [Related]
3. Mutation of the PIK3CA gene in anaplastic thyroid cancer. García-Rostán G; Costa AM; Pereira-Castro I; Salvatore G; Hernandez R; Hermsem MJ; Herrero A; Fusco A; Cameselle-Teijeiro J; Santoro M Cancer Res; 2005 Nov; 65(22):10199-207. PubMed ID: 16288007 [TBL] [Abstract][Full Text] [Related]
4. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527 [TBL] [Abstract][Full Text] [Related]
5. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
7. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Weng LP; Gimm O; Kum JB; Smith WM; Zhou XP; Wynford-Thomas D; Leone G; Eng C Hum Mol Genet; 2001 Feb; 10(3):251-8. PubMed ID: 11159944 [TBL] [Abstract][Full Text] [Related]
8. Genetic alterations in the RAS/RAF/mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways in the follicular variant of papillary thyroid carcinoma. Santarpia L; Myers JN; Sherman SI; Trimarchi F; Clayman GL; El-Naggar AK Cancer; 2010 Jun; 116(12):2974-83. PubMed ID: 20564403 [TBL] [Abstract][Full Text] [Related]
9. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. St-Germain ME; Gagnon V; Parent S; Asselin E Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin. Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518 [TBL] [Abstract][Full Text] [Related]
11. AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374 [TBL] [Abstract][Full Text] [Related]
12. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues. Weyemi U; Caillou B; Talbot M; Ameziane-El-Hassani R; Lacroix L; Lagent-Chevallier O; Al Ghuzlan A; Roos D; Bidart JM; Virion A; Schlumberger M; Dupuy C Endocr Relat Cancer; 2010 Mar; 17(1):27-37. PubMed ID: 19779036 [TBL] [Abstract][Full Text] [Related]
13. Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation. Younes MN; Yigitbasi OG; Park YW; Kim SJ; Jasser SA; Hawthorne VS; Yazici YD; Mandal M; Bekele BN; Bucana CD; Fidler IJ; Myers JN Cancer Res; 2005 Jun; 65(11):4716-27. PubMed ID: 15930290 [TBL] [Abstract][Full Text] [Related]
14. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Sinha D; Wang Z; Ruchalski KL; Levine JS; Krishnan S; Lieberthal W; Schwartz JH; Borkan SC Am J Physiol Renal Physiol; 2005 Apr; 288(4):F703-13. PubMed ID: 15572521 [TBL] [Abstract][Full Text] [Related]
15. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors. Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247 [TBL] [Abstract][Full Text] [Related]
16. Tumorigenic and metastatic activity of human thyroid cancer stem cells. Todaro M; Iovino F; Eterno V; Cammareri P; Gambara G; Espina V; Gulotta G; Dieli F; Giordano S; De Maria R; Stassi G Cancer Res; 2010 Nov; 70(21):8874-85. PubMed ID: 20959469 [TBL] [Abstract][Full Text] [Related]
17. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Menendez JA; Colomer R; Lupu R Med Hypotheses; 2005; 64(2):342-9. PubMed ID: 15607569 [TBL] [Abstract][Full Text] [Related]
18. The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Tu Y; Gardner A; Lichtenstein A Cancer Res; 2000 Dec; 60(23):6763-70. PubMed ID: 11118064 [TBL] [Abstract][Full Text] [Related]
19. Involvement of Ras activation in human breast cancer cell signaling, invasion, and anoikis. Eckert LB; Repasky GA; Ulkü AS; McFall A; Zhou H; Sartor CI; Der CJ Cancer Res; 2004 Jul; 64(13):4585-92. PubMed ID: 15231670 [TBL] [Abstract][Full Text] [Related]
20. Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors. Wu G; Mambo E; Guo Z; Hu S; Huang X; Gollin SM; Trink B; Ladenson PW; Sidransky D; Xing M J Clin Endocrinol Metab; 2005 Aug; 90(8):4688-93. PubMed ID: 15928251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]